Wockhardt Ltd
Asif Sayyad is a highly experienced research professional in the field of biosimilars and drug product development. Currently serving as a Team Lead in Biosimilar Formulation and Drug Product Development at Wockhardt Ltd. since December 2021, Asif has previously held positions at Dr. Reddys Biologics, Hetero Biopharma, and Julphar Gulf Pharmaceutical Industries, where responsibilities included formulation and development of biosimilars and injectables. With a strong background in technology transfer and aseptic processing, Asif's career began at Mabpharm Pvt Ltd, focusing on biosimilar injectable technologies. Asif holds a Master’s degree in Pharmaceutics and Drug Design from Savitribai Phule Pune University and is currently pursuing a Ph.D. in Pharmaceutical Sciences at MGM University.
This person is not in the org chart
This person is not in any offices
Wockhardt Ltd
1 followers
Wockhardt Limited is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Aceroc, Alphadopa, Biovac Typhoid, Acetic Acid Otic Solution, Amlodipine Besylate Tablets, Adenosine Injection, Amoxicillin and Clavulanate Potassium for Oral Suspension, Azithromycin Tablets, Aciclovir Powder for Injection, Alendronic Acid, Amitriptyline, Clarithromycin, Entacapone Tablet and Flucloxacillin Injection. It operates a chain of approximately 10 super specialty hospitals, which offer treatment and care facilities in cardiology, neurosurgery, orthopedics, critical care, oncology, nephrology, urology and others. It has over 10 manufacturing plants located in India, the United Kingdom, Ireland and the United States. The Company has approximately three research centers globally.